NEW YORK (GenomeWeb) – MDxHealth said today that American Pathology Partners will promote and co-market the firm's ConfirmMDx for Prostate Cancer test in the US.
American Pathology Partners is building a network of pathology labs in the US and has partnered in that effort with UniPath in Denver, Palm Beach Pathology in West Palm Beach, Fla., and Eastern Carolina Pathology in Wilson, NC. MDxHealth said the agreement extends its customer base to pathologists serving urologists in key geographic markets.
Financial and other terms of the agreement weren't disclosed.
ConfirmMdx is an epigenetic assay that helps urologists distinguish patients with true-negative biopsies from those at risk for occult cancer.